Kiniksa Pharmaceuticals International (KNSA) Accumulated Depreciation & Amortization (2021 - 2025)
Historic Accumulated Depreciation & Amortization for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $7.8 million.
- Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization fell 354.1% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 354.1%. This contributed to the annual value of $8.2 million for FY2024, which is 524.08% up from last year.
- According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization is $7.8 million, which was down 354.1% from $7.8 million recorded in Q2 2025.
- Kiniksa Pharmaceuticals International's 5-year Accumulated Depreciation & Amortization high stood at $8.2 million for Q4 2024, and its period low was $5.0 million during Q1 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $7.1 million, with a median of $7.4 million in 2023.
- As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization surged by 2498.01% in 2022, and later plummeted by 354.1% in 2025.
- Over the past 5 years, Kiniksa Pharmaceuticals International's Accumulated Depreciation & Amortization (Quarter) stood at $5.9 million in 2021, then rose by 15.96% to $6.9 million in 2022, then grew by 13.5% to $7.8 million in 2023, then increased by 5.24% to $8.2 million in 2024, then fell by 4.58% to $7.8 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $7.8 million for Q3 2025, versus $7.8 million for Q2 2025 and $7.8 million for Q1 2025.